The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory CommitteeElı́as Campo, Ari Melnick, Andrew D. Zelenetz et al.|Blood|2022Cited by 1.5k
Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell MalignanciesRanjana H. Advani, Nathan Fowler, Joseph J. Buggy et al.|Journal of Clinical Oncology|2012Cited by 1.1k
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s LymphomaRanjana H. Advani, Sonali M. Smith|New England Journal of Medicine|2018Cited by 1.1k
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphomaWyndham H. Wilson, Louis M. Staudt, Ryan M. Young et al.|Nature Medicine|2015Cited by 1.1k
Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell LinesAshley A. Powell, Stefanie S. Jeffrey, AmirAli Talasaz et al.|PLoS ONE|2012Cited by 528